As newborn genomic screening initiatives continue to unfold around the world, the ethical and responsible implementation of the approach into public health sparked vibrant discussions at the American College of Medical Genetics and Genomics (ACMG) annual meeting last week.
In addition to updates from notable newborn genomic screening studies — such as the UK’s Generation Study and the Building Evidence and Collaboration for Genomics in Nationwide Newborn Screening (BEACONS-NBS, formerly known as BEACONS) program — during the meeting, clinicians, genetic counselors, and researchers also voiced their opinions and concerns about the approach, which many perceive as becoming inevitable.
